General Information of Drug (ID: DMWBWNG)

Drug Name
Dinutuximab
Indication
Disease Entry ICD 11 Status REF
Small-cell lung cancer 2C25.Y Phase 2/3 [1]
Neuroblastoma 2D11.2 Investigative [2]
Cross-matching ID
TTD ID
D0EP9A
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386.